title: Protection against fatal endotoxin shock in mice by antihistamines.
abstract: Protection against endotoxin shock by antihistamines and similar pharmacologic agents has been reported in the literature. The authors tested the validity of this form of treatment by animal experiments which were conducted in three phases. During the first phase, 10 mice each were treated intravenously with various doses of gram negative endotoxin to determine the dose of endotoxin which would kill 80% of the animals (LD80). This dose was determined to be 36 mg/kg bodyweight. During the second phase, 10 mice each were pretreated with various doses of either diphenhydramine (Benadryl) or of hydroxyzine HCI (Atarax) one hour prior to the administration of the LD80 of endotoxin. It appeared that high doses of diphenhydramine as well as of hydroxyzine were highly fatal to most animals by causing severe convulsions within 3 to 6 hours at doses of 40 or 50 mg/kg. Doses of less than 1 mg/kg appeared to have no protective effect, while doses of 2.5 and of 5 mg/kg, given one hour prior to the LD80 of endotoxin, had some protective value. In the case of diphenhydramine, 60% of the animals survived with 5 mg/kg pretreatment. Hydroxyzine hydrochloride protected 100% of the 10 animals so treated during the initial experiment and 90% during a subsequent experiment, if given 1 hour before the endotoxin. The third phase of this experiment was designed to determine the optimal time at which hydroxyzine needs to be given to protect against fatal endotoxin shock. Given 6 hours before endotoxin, hydroxyzine appeared to protect half of the animals, 1 hour prior to endotoxin, 5 mg/kg of hydroxyzine protected 90% of animals; if given simultaneously, it protected all animals. When hydroxyzine was given 1 hour after endotoxin there was a 70% survival and, if given 3 hours after endotoxin, a 40% survival.
mesh_terms: D000818:Animals; D004155:Diphenhydramine / Q000008:administration & dosage; D004341:Drug Evaluation; D004927:Escherichia coli Infections / Q000188:drug therapy* / Q000517:prevention & control; D006634:Histamine H1 Antagonists / Q000008:administration & dosage*; D006919:Hydroxyzine / Q000008:administration & dosage; D007275:Injections, Intravenous; D007928:Lethal Dose 50; D051379:Mice; D012772:Shock, Septic / Q000517:prevention & control*
chemical_list: D006634:Histamine H1 Antagonists; D006919:Hydroxyzine; D004155:Diphenhydramine